In another study evaluating colorectal cancer development, Kagawa et al. showed that ARHGAP11A was significantly upregulated in colon cancers and that its expression levels correlated with clinical invasion status, which may result from suppression of RhoA and increased Rac1 activity [36]. This evidence concerns the gene ARHGAP11A and colonic neoplasm.